Correlation Between Apogee Therapeutics, and IPG Photonics

Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and IPG Photonics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and IPG Photonics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apogee Therapeutics, Common and IPG Photonics, you can compare the effects of market volatilities on Apogee Therapeutics, and IPG Photonics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of IPG Photonics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and IPG Photonics.

Diversification Opportunities for Apogee Therapeutics, and IPG Photonics

0.14

Correlation Coefficient

Apogee Therapeutics,  IPG Photonics

Average diversification

The 3 months correlation between Apogee and IPG is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and IPG Photonics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IPG Photonics and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with IPG Photonics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IPG Photonics has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and IPG Photonics go up and down completely randomly.

Pair Corralation between Apogee Therapeutics, and IPG Photonics

Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to under-perform the IPG Photonics. In addition to that, Apogee Therapeutics, is 1.83 times more volatile than IPG Photonics. It trades about -0.05 of its total potential returns per unit of risk. IPG Photonics is currently generating about 0.17 per unit of volatility. If you would invest  7,135  in IPG Photonics on May 6, 2025 and sell it today you would earn a total of  387.00  from holding IPG Photonics or generate 5.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Apogee Therapeutics, Common  vs.  IPG Photonics

Apogee Therapeutics,

Risk-Adjusted Performance

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Apogee Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Apogee Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in September 2025.

IPG Photonics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in IPG Photonics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak technical and fundamental indicators, IPG Photonics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Apogee Therapeutics, and IPG Photonics

The main advantage of trading using opposite Apogee Therapeutics, and IPG Photonics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, IPG Photonics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IPG Photonics will offset losses from the drop in IPG Photonics' long position.

The idea behind Apogee Therapeutics, Common and IPG Photonics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.